It’s no secret: Cancer treatments are powerful. It’s also no secret that these drugs can also harm healthy cells in the body, which can lead to side effects. It’s not uncommon for patients to feel nauseous or experience a loss of appetite as a result of treatment. While there are medications you can take to … Continued
The Older Adults with GI Malignancies Program (OAGM) is hosting a webinar series in 2025 for older adult patients (age 65+) and their care partners.…
One of the goals of the Ending Metastatic Breast Cancer for Everyone (EMBRACE) program at Dana-Farber Cancer Institute is to provide resources and information to…
Join us for a live webinar on The Next Generation of Cancer Treatments with Dana-Farber’s Scott Armstrong, MD, PhD, Senior Vice President for Drug Discovery…
A new generation of drugs and drug combinations are improving the outlook for patients with endometrial (uterine) cancer.
Published: May 24, 2021Updated: December 4, 2023Written by: Beth DoughertyMedically Reviewed By: Patrick Ott, MD, PhDKey Takeaways: The goal of cancer vaccines is to spur…
The Dana-Farber Center for RAS Therapeutics is a multi-disciplinary initiative that seeks to advance novel treatment approaches to transform the lives of patients with RAS-driven…
Discover the connection between alcohol consumption and elevated cancer risk.
The Connell and O’Reilly Families Cell Manipulation Core Facility (CMCF) at Dana-Farber Cancer Institute is a state-of-the-art academic GMP laboratory dedica…
The Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber provides state-of-the-art and compassionate care for breast cancer patients.
Dana-Farber Cancer Institute Faculty highlights from the 2024 San Antonio Breast Cancer Symposium.
